BOLETÍN HTA

HIPERTENSIÓN / 2018 / VOL. 23 21 Referencias 1.-Mahmood SS, Levy D, Vasan RS, Wang TJ. e Framingham Heart Study and the epidemiology of cardiovascular diseases: a historical perspective. Lancet. 2014;383:999-1008 2.-Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:1475– 82. 3.- Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335:136 4.- Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study. Circulation 2002;105:310 –5. 5.- Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation. 2008 Nov 25. 118 (22):2243-51 6.- Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardio vascular risk in women: the Reynolds Risk Score. JAMA 2007;297: 611–9. 7.-World Health Organization Website. Available at: http://www.who.int . Visitado el 14 de diciembre 2019. 8.- Ministerio de Salud. Enfoque de riesgo para la prevención de enfermedades cardiovasculares. Consenso 2014. http://www.enfermeriaaps.com/portal/ consenso-minsal-chile-2014-enfoque-de-riesgo-para-la-prevencion-de-enfermedades-cardiovasculares Visitado el 14 de diciembre 2019. 9.-Icaza G, Nuñez L, Marrugat J, Mujica V, Escobar MC, Jiménez A, etet al., “Estimación de riesgo de enfermedad coronaria mediante la función de Framingham adaptada para la población chilena”, Revista médica de Chile 137, no. 10 (2009): 1273-82, 10.- Kunstmann S, Lira MT, Icaza G, Núñez L, De Grazia R estratificación de riesgo cardiovascular en la población chilena Rev. Med. Clin. Condes - 2012; 23(6) 657-665 11.-Goff DC Jr, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24. 129 (25 Suppl 2):S49-73 12.- Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013 Nov 30. 382 (9907):1762-5. 14.- Acevedo M, Valentino G, Kramer V, Bustamante MJ, Adasme M, Orellana L,et al. Superioridad del nuevo puntaje de riesgo ACC/AHA 2013 por sobre el puntaje de Framingham, en la predicción de riesgo de mortalidad cardiovascular en Santiago. Rev Med Chil. 2017; 145(3):292-298. 15.- Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003